Commentary to provide context and explain significance of research is sometimes just as important as the research itself. That’s why our experts make it a priority to provide you with helpful content distilled from the many years of experience our team has accumulated. The Drug Development Insights blog contains overviews and deep dives into the drug metabolism and pharmacokinetics topics you care about—regulatory expectations, risk assessment, safety considerations, scientific innovation, study design elements, interpretation of results, and more. Explore our entries chronologically or by category to get insight into the many pieces of your drug’s development.
Drug Development Blog
Pharmaceutical Outsourcing Magazine Interview Nov-Dec 2016
- Updated Offerings
- November 29, 2016
- Michael Millhollen
For their November/December 2016 issue, Pharmaceutical Outsourcing Magazine interviewed Chris Bohl, PhD, Global Technical Support Manager for XenoTech’s Products Division, on the...
XenoTech Standardizes Lysosomal Test Systems for Biopharmaceutical Development
- Test Systems & Methods
- October 5, 2016
- Dr. Chris Bohl
Before releasing these test systems, there was not a high quality, specific, relevant, easy and ready to use, in vitro test system to...
XenoTech Joins Fight Against Liver Disease
- Disease-Specific Resources
- September 16, 2016
- Dr. Maciej Czerwinski, Michael Millhollen
XenoTech is committed to furthering the knowledge surrounding hepatic diseases, such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis...
XenoTech Featured on Labiotech.EU
- Enzyme Inhibition
- July 5, 2016
- Michael Millhollen
Understand which transporters are involved in a drug’s absorption, distribution & excretion Originally posted on Labiotech.EU How can you build the...
XenoTech Scientists Publish Paper, Present Research Evaluating Ketoconazole and its Alternative Clinical CYP3A4-5 Inhibitors as Inhibitors of Drug Transporters
- Enzyme Inhibition
- April 25, 2016
- Michael Millhollen
XenoTech scientists published a paper in Drug Metabolism and Disposition evaluating Ketoconazole and its alternative clinical CYP3A4-5 inhibitors as inhibitors of drug...
XenoTech Fulfills Largest Order To Date
- Accomplishments
- February 1, 2016
- Michael Millhollen
XenoTech recently fulfilled its largest order of human liver subcellular fractions to date. A large pharmaceutical customer ordered over 30,000...
XenoTech Hosts Bring Your Kids to Work Day
- Our Team
- May 4, 2015
- Matthew Beck, Michael Millhollen
On Thursday, April 23rd, XenoTech participated in “bring your child to work day”. At XenoTech, we are passionate about what...
Navigating the Transporter Wave of 2013
- Regulatory Guidance
- August 28, 2013
- Greg Loewen
The International Transporter Consortium (ITC) issued 7 papers in the July 2013 issue of Clinical Pharmacology & Therapeutics. These 7...
Subscribe to our Newsletter
Stay up to date with our news, events and research
Do you have a question or a request for upcoming blog content?
We love to get your feedback